Bullets:

PHARMA SUFFIXES 1
COMPILED BY : EMMANUEL D. CUNA
Bravezetfortxtra.blogspot.com
Emmancuna.blogspot.com

(-olol) beta 1 blockers (adrenergic)

(-cillin, -micin) antibiotics
(-vastatin) antihyperlipidemia, antihypercholesterolimia
(-tidine) anti-ulcerant, H2 receptor antagonist; preventive treatment, no signs of ulcers
(-pine) Ca-channel blocker, anti-HPN; affects the blood vessel of heart
(-rin) anticoagulant, anti-HPN; affects the blood vessels of the heart
(-dol) non-opioid analgesic
(-done) opioid analgesics
(-sone) corticosteroids, anti-inflammatory
(-nitrate) anti-anginal, vasodilator
(-nol) antigout
(-mine) anti-histamine
(-sartan) ACE II antagonist, affects the kidney
(-kinase) anti-thrombolitic, thrombolitic agent
(-pril) ACE I inhibitors, affects the kidney
(-mide) loop diuretics
(-lactone) potassium-sparing diuretics
(-prazole) proton-pump inhibitors; with evidence of ulcers scars
(-mol) bronchodilators, beta 2 adrenergic; for DOB
(-pium) beta 2 adrenergic; for DOB, relaxes bronchi
(-aluminum, magnesium, hydroxide) antacids
(-zepam, -lam) anti-anxiety, major tranquilizers
(caine) local anesthetics
(-ide) oral hypoglycemics
(-nium) neuromuscular blocking agent
(-vir) antivirals

Drugs that affect the endocrine system

Antidiabetics
Insulins: rapid-acting
(Humulog, Humulin R),
intermediate-acting (NPH
insulin, Humulin N), mixed
(Humulin 70/30), long
acting (Ultralente U,
Humulin U)
Oral Antidiabetics:
Acetohexamide (Dymelor),
Chlorpropamide
(Diabenese), Glimipiride
(Amaryl), Glipizide
(Glucotrol), Glyburide
(Micronase), Tolazamide
(Tolinase), Tolbutamide
(Orinase)
Biguanide: Metformin
(Glucophage)
Alpha Glucosidase
Inhibitors: Acarbose
(Precose), Miglitol (Glyset)
 Insulin: Type 1 and  Hypersensitivity to a  Hypoglycemia  Monitor blood glucose
Type 2 diabetes specific insulin  Lipodystrophy levels.
mellitus when oral  Hypoglycemia (Insulin)  Assess the patient for signs
antidiabetics, diet  Renal impairment,  Weight gain, GI and symptoms of
and weight control hepatic dysfunction, upset, anorexia, hypoglycemia and
are ineffective. alcohol abuse nausea and diarrhea hyperglycemia.
 Oral antidiabetic: (Metformin) (Metformin)  Assess dietary habits and
Type 2 diabetes  Concomitant  Vitamin B12 the patient’s knowledge of
mellitus administration of malabsorption diet restrictions.
 Biguanide: Type 2 other drugs with (Metformin)  Monitor actual dietary
diabetes (used to renal tubular  Risk of lactic intake.
decrease hepatic excretion such as acidosis with kidney  Make sure the patient and
production of cimetidine disease (Metformin) his family are taught about
glucose) (Metformin)  Flatulence, diabetes and its treatment,
 Alpha glucosidase  Impaired liver abdominal distention including medications, diet,
inhibitor: Type 2 function (Acarbose) and diarrhea insulin monitoring,
diabetes (blocks  Type 1 Diabetes (Acarbose) hypoglycemia and
absorption of hyperglycemia, and the
(Repaglinide)  May increase liver
carbohydrate) effects of illness and stress.
function test results
 Meglitinide: Type 2 (Acarbose)
diabetes (stimulates
Maglitinide: Repaglinide release of insulin
(Prandin) from pancreas)
Thiazolidinedione:  Thiazolidinedione:
Rosiglitazone (Avandia) Type 2 diabetes
(reduces cellular
insulin resistance)

Antithyroids
Methimazole (Tapazole),  Hyperthyroidism  Pregnancy and  Rash  Assess the patient’s
Potassium Iodide,  Grave’s Disease lactation  Nausea and vomiting nutritional status
Propylthiouracil, Sodium  Hypersensitivity to  Anorexia  Monitor T3 and T4 levels
Iodide iodine or iodide  Hypothyroidism  Monitor weight weekly.
preparations  Tell the patient to take the
medication at the same
time everyday.

Thyroid Hormones
Levothyroxine  Supplement or  Hyperthyroidism  Tachycardia  Assess the patient’s
(Synthroid),Thyroid (Thyrar) replace natural  Thyrotoxicosis  Nervousness nutritional status
thyroid hormone  Untreated adrenal  Insomnia  Monitor T3 and T4 levels.
 Hypothyroidism, insufficiency  Increased appetite  Administer the drug in the
myxedema, goiter,  Acute MI  Weight loss morning to prevent
postthyroidectomy insomnia
 Assess the patient for
symptoms of cardiovascular

Common Drugs Indications Contraindications Adverse reactions Nursing implications

disease.

Adrenocorticosteroids  Replacement  Peptic ulcer disease  Water and sodium  Monitor weight, blood
Cortisone Acetate therapy in patients  Tuberculosis retention pressure and blood counts.
(Cortone), Dexamethasone with adrenal  Severe infections  Mood swings  Administer oral doses with
(Decadron), Hydrocortisone insufficiency  Autoimmune  Hyperglycemia milk or food to decrease the
Sodium Succinate (Solu-  Shock (to increase disorders, heart  Acne and facial hair risk of GI distress
Cortef), Methylprednisolone cardiac output and failure, diabetes and growth  Assess the patient for signs
(Medrol), blood pressure) glaucoma (use with  GI distress and symptoms of fluid
Methyprednisolone Sodium  Inflammatory caution)  Masked signs of retention, hypokalemia,
Succinate (Solu-Medrol), disorders, such as infection hyperglycemia and mental
Prednisolone (Prelone), joint diseases, GI changes.
 Hypokalemia
Predsnisone (Deltasone), disorders, and skin  Wean the patient from
Triamcinolone (Aristoicort allergies steroid therapy.
 Cerebral edema  Tell the patient to avoid
infected people,
immunizations, and
vaccinations and skin
testing.

Read: Chemotherapeutic Drugs

DOH Programs
Health Programs
By carol
Published: 2008-01-23 11:03
- Adolescent and Youth Health and Development Program
- Botika Ng Barangay
- Breastfeeding Program / Mother and Baby Friendly Hospital Initiative
- Blood Donation Program
- Cancer Control Program
- Child Health
- Diabetes Mellitus Prevention Program
- Dengue Control Program
- Dental Health Program
- Doctors to the Barrios (DttB) Program
- Emerging Disease Control Program
- Environmental Health
- Expanded Program on Immunization
- Family Planning
- Food and Waterborne Diseases Prevention and Control Program
- Food Fortification Program
- FOURmula One
- Garantisadong Pambata
- GMA 50 / Parallel Drug Importation (PDI)
- Human Resource Health Network
- Healthy Lifestyle Program
- Health Sector Development Program
- Knock-Out Tigdas
- Leprosy Control Program
- Malaria Control Program
- Measles Elimination Campaign (Ligtas Tigdas)
- National Cardiovascular Disease Prevention and Control Program
- National Filariasis Elimination Program
- National Mental Health Program
- Natural Family Planning
- Newborn Screening
- Nutrition
- Occupational Health Program
- Health Development Program for Older Persons (Elderly Health)
- Pinoy MD
- Persons with Disabilities Program
- Pnuemonia and Other Acute Respiratory Infections (ARI's)
- Prevention of Blindness Program
- Rabies Control Program
- Safe Motherhood and Women's Health
- Schistosomiasis Control Program
1/2
- Smoking Cessation Program
- Soil Transmitted Helmenthiasis
- TB Control Program

Principles of Primary Health Care

Primary health care became a core policy for WHO in 1978, with the adoption of the Declaration of Alma-Ata and
the strategy of "Health for all by the year 2000".

Core Principles:
 universal access to care and coverage on the basis of need;
 commitment to health equity as part of development oriented to social justice;
 community participation in defining and implementing health agendas;
 intersectoral approaches to health.

R.A. 9288 or the Newborn Screening Act of 2004 was enacted, when a national comprehensive newborn
screening system was established.

The five congenital disorders included in the Philippine newborn screening are:

--congenital hypothyroidism (CH), resulting from the lack or absence of thyroid hormone which is
essential for brain and body growth. If not detected and hormone replacement is not initiated within four
weeks, the baby's physical growth will be affected and may suffer from mental retardation;

--congenital adrenal hyperplasia (CAH), an endocrine disorder that causes severe salt loss, dehydration
and abnormally high level of male sex hormones in both boys and girls and if not detected and treated
early, infants may die within seven to 14 days;

--galactosemia (GAL), a condition in which infants are unable to process galactose or the sugar present
in milk and accumulation of excessive galactose in the body can cause liver and brain damages, cataracts
and other problems;

--phenylketonuria (PKU), a rare condition when infants cannot properly use one of the building blocks of
protein called phenylalanine and its excessive accumulation in the blood causes brain damage; and

--glucose-6-phosphate-dehydrogenase deficiency (G6PD def), this when body lacks the enzyme and
infants with this condition may have hemolytic anemia.

If infants with these conditions are screened and treated, they can be save from the irreversible defects
and live normal lives.
Newborn screening is ideally done on the 48th to 72 hour of life, however this may also be done 24 hours
from birth.

OB-ER cases
 cord prolapse
 placenta previa
 abruption placenta
 fetal distress etc etc

Immunizations
Primary Health Care
Spinal catheter-